Go
View All
Second-generation antipsychotics - approximate equivalent doses
Selected clinical features and risks in people with 22q11.2 deletion syndrome.
Severe alcohol withdrawal
Short Alcohol Withdrawal Scale (SAWS)
Some notes on currently and historically used medications for behaviour disorder
Starting treatment with Aristada
Stimulants in depression
Suggested monitoring for myocarditis
Suggested options for augmenting clozapine
Summary of alternatives to clozapine in refractory schizophrenia
Summary of antipsychotic/oestrogen interactions
Summary of British Association for Psychopharmacology recommendations
Summary of haematological changes associated with psychotropics
Summary of pharmacotherapy for depression in children and adolescents
Summary of psychiatric adverse drug reactions (ADRs) with non-psychotropics
Sedatives in hepatic impairment
Severe alcohol dependence: example of a fixed-dose chlordiazepoxide regimen
Sexual adverse effects of antipsychotics
Sites of administration of intramuscular injections
Starting doses of commonly used psychotropic drugs in children and adolescents
Stimulants in breastfeeding
Stimulants in hepatic impairment
Suggested monitoring for people receiving antipsychotic medication
Suggested titration regimens for initiation of clozapine in the community
Summary of antidepressant effects on CYP enzymes
Summary of biochemical changes associated with psychotropics
Summary of drugs of misuse
Summary of maintenance in bipolar disorder
Summary of psychiatric adverse drug reactions (ADRs) with antiretroviral drugs
Summary of recommendations
Displaying items 1 - 30 of 39